The Mumps Measles Rubella (MMR) vaccine is a combination vaccine that provides protection against three highly contagious viral infections: mumps, measles, and rubella. It is administered through a single injection and is typically given in two doses, with the first dose administered at around 12 to 15 months of age and the second dose given between 4 to 6 years old.
Mumps is a viral infection characterized by swelling and inflammation of the salivary glands, particularly the parotid glands, located below and in front of the ears. Measles, also known as rubeola, is a highly contagious respiratory infection that causes fever, cough, runny nose, a rash, and other symptoms. Rubella, also referred to as German measles, is a mild viral infection characterized by a rash and fever.
The MMR vaccine contains weakened or inactivated forms of the viruses responsible for causing mumps, measles, and rubella. When administered, the vaccine stimulates the body's immune system to produce protective antibodies, which help fight off these viruses if exposed to them in the future.
The MMR vaccine has been proven to be highly effective at preventing these diseases and their complications, such as pneumonia, encephalitis (inflammation of the brain), deafness, and even death. It is a crucial immunization recommended by healthcare professionals to protect individuals, especially children, from these potentially severe and debilitating infections.
